407 related articles for article (PubMed ID: 6749608)
1. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
Abai AM; Fekete B
Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
[TBL] [Abstract][Full Text] [Related]
2. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man.
Fleer A; van der Hart M; Blok-Schut BJ; Schellekens PT
Eur J Immunol; 1976 Mar; 6(3):163-7. PubMed ID: 791653
[TBL] [Abstract][Full Text] [Related]
3. Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.
Repo H; Kostiala AA; Kosunen TU
Clin Exp Immunol; 1980 Feb; 39(2):442-8. PubMed ID: 6993072
[TBL] [Abstract][Full Text] [Related]
4. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
Cervantes C; Muzio E; Exposito G; Garcia ME
Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
[TBL] [Abstract][Full Text] [Related]
5. Participation of a histamine-Sepharose-adherent subpopulation of human mononuclear cells in the production of leucocyte migration inhibition factor (LIF) in healthy children.
Reichman BL; Handzel ZT; Segal S; Weinstein Y; Levin S
Clin Exp Immunol; 1979 Sep; 37(3):562-6. PubMed ID: 389498
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity against digestive organ cancers : leucocyte migration inhibitory factor activity as an immunological parameter.
Hamasaki K
Acta Med Okayama; 1977 Jun; 31(3):147-59. PubMed ID: 144415
[TBL] [Abstract][Full Text] [Related]
7. [Examination of cell-mediated immunity using the leukocyte migration inhibition test in agarose].
Zimmermann S; Felber F
Z Gesamte Inn Med; 1977 Feb; 32(4):54-5. PubMed ID: 855396
[TBL] [Abstract][Full Text] [Related]
8. Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients.
Suslov I; McCoy JL; Herberman RB
J Natl Cancer Inst; 1981 Feb; 66(2):233-7. PubMed ID: 7005504
[TBL] [Abstract][Full Text] [Related]
9. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
Hashimoto Y; Sekiguchi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
[TBL] [Abstract][Full Text] [Related]
10. Correlation of in vitro and in vivo tests for cell-mediated immunity in the dog.
Thilsted JP; Shifrine M; Wiger N
Am J Vet Res; 1979 Sep; 40(9):1313-5. PubMed ID: 525939
[TBL] [Abstract][Full Text] [Related]
11. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of immune response indices in lung cancer].
Govallo VI; Dubrovskiĭ AV; Grigor'eva MP; Kosmiadi GA; Efimtseva NN
Vopr Onkol; 1985; 31(1):39-44. PubMed ID: 3156450
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
[TBL] [Abstract][Full Text] [Related]
14. Comparison of direct and indirect migration inhibition tests and skin hypersensitivity to tuberculin (PPD).
Mrázová A; Vejbora O; Fixa B
J Hyg Epidemiol Microbiol Immunol; 1981; 25(1):42-51. PubMed ID: 7229355
[TBL] [Abstract][Full Text] [Related]
15. Increased migration inhibition factor production by leukocytes of patients with herpes zoster given the leukocyte ultrafiltrate.
Lackovicová M; Zachar V; Necas S; Mayer V
Acta Virol; 1989 Sep; 33(5):428-34. PubMed ID: 2576583
[TBL] [Abstract][Full Text] [Related]
16. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.
Bullen AW; Losowsky MS
Clin Exp Immunol; 1978 Mar; 31(3):408-13. PubMed ID: 350459
[TBL] [Abstract][Full Text] [Related]
18. [In vitro transfer of immunity against PPD with dialyzable extract of leukocytes from human colostrum].
Martínez-Cairo Cueto S; Alasio-Chávez C; Dávila Velázquez JR
Rev Alerg; 1992; 39(6):126-32. PubMed ID: 1492196
[TBL] [Abstract][Full Text] [Related]
19. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity in chronic polymorphous light eruptions. Leukocyte migration inhibition assay with irradiated skin as antigen.
Jansén CT; Helander I
Acta Derm Venereol; 1976; 56(2):121-5. PubMed ID: 58520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
